Servier Acquires Day One Biopharmaceuticals to Boost Oncology Pipeline

French pharmaceutical group Servier has announced the acquisition of US biotech company Day One Biopharmaceuticals.

Published 20sem2 sources✓ ConfirmedNotableupdated 20sem

≈ 18sSpeed

The fact

The deal aligns with Servier's strategic refocus on oncology, a key therapeutic area.

The transaction strengthens the French group's cancer treatment portfolio.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on April 23, 2026